Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 591-600 of 2916 for cancer

Edit search filters
  1. Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary

    Rochester, MN

  2. AI-Augmented Imaging For Early Detection Of Pancreatic Cancer Acronym: AI-PACED

    Rochester, MN

  3. (Neo)Adjuvant IDE196 (Darovasertib) In Patients With Localized Ocular Melanoma

    Rochester, MN

  4. A First-in-Human (FIH) Study To Evaluate The Safety And Tolerability Of VVD-159642 In Participants With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ

  5. Lead-212 PSV359 Therapy For Patients With Solid Tumors

    Rochester, MN

  6. Pemigatinib To Treat Metastatic Or Unresectable Colorectal Cancer Harboring FGFR Alterations

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. PSMA PET For Metastatic Adenoid Cystic Carcinoma (ACC)

    Rochester, MN

  8. Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment-Naïve Mantle Cell Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. A Study Of NT-175 In Adult Participants With Advanced Malignancies That Are Positive For HLA-A*02:01 And The TP53 R175H Mutation

    Jacksonville, FL

  10. A Study Of LY4152199 In Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

    Rochester, MN

.

Mayo Clinic Footer